Complementary whole-genome technologies reveal the cellular response to proteasome inhibition by PS-341.

ABSTRACT: Although the biochemical targets of most drugs are known, the biological consequences of their actions are typically less well understood. In this study, we have used two whole-genome technologies in Saccharomyces cerevisiae to determine the cellular impact of the proteasome inhibitor PS-341. By combining population genomics, the screening of a comprehensive panel of bar-coded mutant strains, and transcript profiling, we have identified the genes and pathways most affected by proteasome inhibition. Many of these function in regulated protein degradation or a subset of mitotic activities. In addition, we identified Rpn4p as the transcription factor most responsible for the cell's ability to compensate for proteasome inhibition. Used together, these complementary technologies provide a gener

SUBMITTER: Fleming JA 

PROVIDER: S-EPMC122213 | biostudies-literature | 2002 Feb

REPOSITORIES: biostudies-literature